Background The COVID-19 pandemic has broadly disrupted biomedical treatment and
research including non-invasive brain stimulation (NIBS). Moreover, the rapid onset of …

COVID-19 is a global pandemic that is expected to infect millions and kill up to hundreds of
thousands of people, with a troubling rise in cases each day [1]. It is first and foremost a …

Following the outbreak of the COVID-19 pandemic, the delivery of face-to-face (F2F)
therapeutic interventions and neuroimaging assessments for children with autism spectrum …

Objective: In light of the COVID-19 pandemic, a majority of clinicians have had to quickly and
dramatically alter their clinical practices. Two surveys were administered on 3/26/2020 and …

The importance of neurorehabilitation services for people with disabilities is getting well-
recognized in low-and middle-income countries (LMICs) recently. However, accessibility to …

The unfolding coronavirus disease 2019 (COVID-19) pandemic is transforming neurological
care more than any other crisis in modern history. Social distancing and quarantine have cut …

Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the
respiratory system, but also affects the nervous system. Non-invasive neuromodulation may …

Most medical centers are postponing elective procedures and deferring non-urgent clinic
visits to conserve hospital resources and prevent spread of COVID-19. The pandemic crisis …

The coronavirus disease of 2019, or COVID-19, changed the world within a matter of weeks.
The primary action to constrain the spread of the virus is social isolation. Given this public …

The management of acute neurological conditions, particularly acute ischemic stroke, in the
context of Coronavirus disease 2019 (COVID-19), is of importance, considering the risk of …